Inventor profile of:

Ping Tsui

City:

Gaithersburg, Maryland

Country:

United States

Published Applications:

16

Last publication date:

2024-04-18

Top Assignees for applications by Ping Tsui

The entities that hold a legal rights for patent applications filed by inventor Tsui Ping:

Recent patent applications by Tsui Ping

Ping Tsui from Gaithersburg, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-04-18
US20240124612A1
Chemistry; metallurgy

MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES

#2 | 2023-06-29
US20230201346A1
Human necessities

BINDING MOLECULES SPECIFIC FOR IL-21 AND USES THEREOF

#3 | 2023-04-13
US20230112035A1
Chemistry; metallurgy

ANTI-avB8 INTEGRIN ANTIBODIES FOR USE IN TREATING KIDNEY DISEASE

#4 | 2021-05-20
US20210147531A1
Chemistry; metallurgy

Nucleic acids encoding anti-VEGF-A antibodies and uses thereof

#5 | 2021-02-11
US20210040194A1
Chemistry; metallurgy

Nucleic acids encoding bispecific anti-VEGF and anti-ANG2 antibodies and uses thereof

#6 | 2020-09-03
US20200277381A1
Chemistry; metallurgy

ALPHA-V BETA-8 ANTIBODIES

#7 | 2020-05-28
US20200164069A1
Human necessities

Antibodies specific for IL-21 and uses thereof

#8 | 2020-03-05
US20200071423A1
Chemistry; metallurgy

Molecules with altered neonate Fc receptor binding having enhanced therapeutic and diagnostic properties

#9 | 2019-07-04
US20190202903A1
Chemistry; metallurgy

Anti-VEGF-A antibodies and uses thereof

#10 | 2019-06-27
US20190194308A1
Chemistry; metallurgy

Anti-VEGF-A and anti-ANG2 antibodies and uses thereof

#11 | 2018-11-08
US20180318416A1
Human necessities

Antibodies specific for IL-21 and uses thereof

#12 | 2018-09-13
US20180258178A1
Chemistry; metallurgy

Molecules with Reduced Effector Function and Extended Half-Lives, Compositions, and Uses Thereof

#13 | 2017-09-21
US20170267780A1
Chemistry; metallurgy

MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES

#14 | 2017-06-22
US20170173149A1
Human necessities

Antibodies specific for IL-21 and uses thereof

#15 | 2017-05-11
US20170129955A1
Chemistry; metallurgy

ALPHA-V BETA-8 ANTIBODIES

#16 | 2015-05-07
US20150125444A1
Chemistry; metallurgy

Molecules with reduced effector function and extended half-lives, compositions, and uses thereof

InventorID:

1151920 ⎘